doxylamini hydrogenosuccinas 10 mg, pyridoxini hydrochloridum 10 mg, cellulosum microcristallinum, magnesii trisilicas, carmellosum natricum conexum, magnesii stearas, silica colloidalis, Überzug: hypromellosum, macrogolum 400, macrogolum 8000, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, talcum, silica colloidalis anhydrica, natrii hydrogenocarbonas, natrii laurilsulfas, E 171, polysorbatum 80, triethylis citras, simeticoni emulsio cum poly(dimethylsiloxani) elastomerum et polysorbatum 65 et silica colloidalis et methylcellulosum et dimeticonum et mono/diglycerida et acidum sulfuricum et E 200 et E 210 0.005 - 0.015 µg, cera carnauba, Drucktinte: lacca, E 129, propylenglycolum, E 132, ammoniae solutio 28 per centum, simeticonum, pro compresso obducto corresp. natrium 0.38 mg.
Packungsbestandteile
Gastric juice resistant tablets
Active Agent
Dose
Doxylamine Hydrogenosuccinate
10 mg
Pyridoxine Hydrochloride
10 mg
Inactive agents
Dose
additional_information
Sulfuric Acid
Ammoniae Solutio
28
Dimeticone
color.
color.
color.
conserv.
0.005-0.015 µg
conserv.
Hypromellosum
Überzug
Drucktinte
Macrogol
8000
Magnesium Trisilicate
Sodium Hydrogen Carbonate
Per Centum
Polysorbatum 80
Propylenglycol
Silica Colloidalis
Silica Colloidalis Anhydrica
Simeticone
Talcum
Source
Data was imported : 06.11.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
